Document is current
Any future updates will be listed below
-
Authors
Van den Eynde, Astrid
Gehrcken, Laura
Verhezen, Tias
Lau, Ho Wa
Hermans, Christophe
Lambrechts, Hilde
Flieswasser, Tal
Quatannens, Delphine
Roex, Gils
Zwaenepoel, Karen
Marcq, Elly
Joye, Philippe
Cardenas De La Hoz, Edgar
Deben, Christophe
Gasparini, Alessia
Montay-Gruel, Pierre
Le Compte, Maxim
Lion, Eva
Lardon, Filip
Van Laere, Steven
Siozopoulou, Vasiliki
Campillo-Davo, Diana
De Waele, Jorrit
Pauwels, Patrick
Jacobs, Julie
Smits, Evelien
Van Audenaerde, Jonas R. M.
-
Funding
Funding for this research was provided by:
Kom op tegen Kanker (Stand up to Cancer), the Flemish cancer society (7878)
BOF grant of the University of Antwerp (FFB210425)
Fonds Wetenschappelijk Onderzoek (G040120N, 1S76421N, 1S72821N, 1S27021N, G053518N)
- License Information
-
More Information
Article History
Received: 22 September 2023
Accepted: 11 January 2024
First Online: 9 February 2024
Declarations
:
: The usage of PDAC patient tissue blocks from the Antwerp Biobank (Antwerp, Belgium; ID: BE71030031000) was approved by the Ethics Committee of the Antwerp University Hospital-University of Antwerp under study reference EC14/47/480 and EC13/47/469. The generation of patient-derived organoids from PDAC patients was carried out after written consent and approved by the Ethics Committee of the Antwerp University Hospital-University of Antwerp under study reference EC14/47/480. Buffy coats from four healthy donors were provided by the Red Cross Flanders and usage was approved by the UZA-UAntwerp Ethics Committee under study reference EC5488. All animal procedures were conducted in accordance with, and approval of, the Animal Ethics Committee of the UAntwerp under registration number 2021-55.
: The authors declare no competing interests.
